DR.REDDY'S LABORATORIES LTD. - Dr Reddys Laboratories Ltd reply to clarification sought by the exchange

	< Back
25 May 2015
The Exchange had sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing in Financial Express on May 22, 2015 titled "Some drugs made by Lupin, DRL & Mylan lose EU approval"<BR><BR>Dr Reddys Laboratories Ltd replied stating "The matter referred to in the news item was ongoing for a small part of our marketed portfolio in Europe. The overall impact on the Company's financials of this development is expected to be quite insignificant. Hence, we did not see a stock exchange notification necessary."
View all announcements for DR.REDDY'S LABORATORIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us